Correlation among pathology, genotype, and patient outcomes in glioblastoma.
about
Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymomaThe 2007 WHO classification of tumours of the central nervous systemTERT promoter mutations in primary and secondary glioblastomas.Advanced MR imaging of gliomas: an updateMass spectrometry imaging as a tool for surgical decision-making.Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomasReview: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapiesSpatial organization and correlations of cell nuclei in brain tumorsGene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model.Surgical resection of malignant gliomas-role in optimizing patient outcome.Prognostic implication of histological oligodendroglial tumor component: clinicopathological analysis of 111 cases of malignant gliomas.Systemic administration of mesenchymal stem cells increases neuron survival after global cerebral ischemia in vivo (2VO).Role of glycosyltransferase PomGnT1 in glioblastoma progression.Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation StatusHypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme?Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.Genetic pathways to primary and secondary glioblastomaTargeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcomeHistological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in GlioblastomaContribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells.Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival.Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.Applications of emerging molecular technologies in glioblastoma multiformeIntravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastomaFamiliality in brain tumors.Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.Status of PI3K inhibition and biomarker development in cancer therapeutics.Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.Glioblastoma Stem Cells: A Neuropathologist's View.Genetic profile of astrocytic and oligodendroglial gliomas.Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment.Further understanding of the pathology of glioma: implications for the clinic.OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.
P2860
Q24652909-FCAEDAD1-5762-4623-8FBA-86982F683F32Q24685772-D2C18830-7EE0-449E-A527-30E2F401B725Q27852506-C5267D52-9B02-46CC-B3B7-E00CC1048BECQ30655700-10A58E3D-9389-4429-B345-6A0E28C69946Q33460052-C22F71E9-28CE-49D7-8F6C-48CE029B2CA6Q33490249-2D062274-8166-4CE1-98C0-BF0FCD39ECA1Q33925544-22BD0DD1-A4F7-4A08-96B9-4CEF0A41EDBBQ34081487-6F46934F-B51D-4FBD-8830-484AD76BBE89Q34116278-1D8C87C3-1CD3-4071-A7D7-A971481B47B9Q34164924-9EBA6763-CEF8-444B-A4FC-FD58DAE2C70BQ34198939-CC836542-FBE7-4751-B00D-8ADD5131A751Q34324963-61A42673-99E4-40BC-8A60-80D419B20792Q34388126-9E4419F1-FA1D-47D2-96AF-98587E199B7FQ34575387-8AED7A23-5120-4E2C-AD1C-4FEAE13732D7Q34886810-8FF17B4A-601A-466E-86DA-3C5E086C100EQ35028828-B5CDE782-2B26-4CA5-B395-4F3A4680E96AQ35227405-F56D9D92-0335-4998-8E08-3BD73079FC55Q35419379-281D6C1B-339A-4437-A48B-A3DB2E4A0929Q35738941-9747B41E-06C0-4C55-B6A2-CE3DC20228F3Q35757144-C70E8E0F-EDC1-47C9-92EB-AF14E9675F23Q35759208-FCA9E4FA-6D0C-424B-BB8C-A6136E953CECQ35845223-F3575853-9CE3-461A-A64C-F52D186972CEQ35901357-E8897C51-F137-4630-AABB-6D0356D9244BQ36201775-098C89D0-9443-4C6C-B074-DDD0ECF56752Q36684457-5493C364-1FF7-49F4-BC88-03A6984D14B1Q36904087-71A36203-E020-4FBA-889A-997738E0217AQ36965370-F197F70D-3BD9-46A5-AF8F-DFE9280CAD42Q37029795-09170B0A-0768-49C8-81D1-D7809C53A6FDQ37178980-DC232776-BEB3-45E8-99B1-B72B0FE784A7Q37312716-72D4B731-B929-4108-9B2E-9226D885F963Q37588308-BAE43EBA-713C-495D-846B-E11B7C58843CQ37601178-C196D4E7-C189-4E58-9890-20418E504AFEQ37807263-B792C2DD-3CD7-4038-8CF8-90102EA2B2E8Q37858440-BD61D197-3617-4575-93A7-9821E901034DQ37976320-1E24A58F-A5D7-4EF4-A9B7-BDD6FDA7E14DQ38203283-8D4790B4-AD8B-49AE-92CE-1120C17EA2D8Q38844945-E2CC3DA7-5465-4629-BB2B-227D608F80FAQ38881390-55D166F1-3906-45B3-BDB3-B1AF97DF4DCEQ39416297-F8FE2298-29B5-48BD-9C90-C1A862A5D710Q39704126-0CC6B889-AF38-4CCF-BB96-78EDD4344F07
P2860
Correlation among pathology, genotype, and patient outcomes in glioblastoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Correlation among pathology, genotype, and patient outcomes in glioblastoma.
@en
Correlation among pathology, genotype, and patient outcomes in glioblastoma.
@nl
type
label
Correlation among pathology, genotype, and patient outcomes in glioblastoma.
@en
Correlation among pathology, genotype, and patient outcomes in glioblastoma.
@nl
prefLabel
Correlation among pathology, genotype, and patient outcomes in glioblastoma.
@en
Correlation among pathology, genotype, and patient outcomes in glioblastoma.
@nl
P2093
P2860
P1476
Correlation among pathology, genotype, and patient outcomes in glioblastoma.
@en
P2093
Hiroko Ohgaki
Pier Luigi Di Patre
Salvatore Vaccarella
Takao Fukushima
Taku Homma
Yasuhiro Yonekawa
P2860
P304
P356
10.1097/01.JNEN.0000235118.75182.94
P577
2006-09-01T00:00:00Z